BMRN vs MATV · P/E 40, rev $1.76B vs rev $1.01B
Biomarin Pharmaceutical Inc (BMRN) versus Mativ Holdings Inc. (MATV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Mativ Holdings Inc. (MATV) is a specialty chemicals company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MATV revenue for 2026-06-30 was $1.01B. Net income was -$8.1M. MATV currently screens at market cap $414.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MATV currently screens at market cap $414.1M.
Not investment advice. Open the BMRN and MATV stock pages for the full models.
Not investment advice.